Market Overview

Carter Worth And Mike Khouw's Amgen Trade

Carter Worth And Mike Khouw's Amgen Trade

On CNBC's Options Action, Carter Worth analyzed Amgen, Inc. (NASDAQ: AMGN) from a technical standpoint.

He said that the stock consistently outperformed iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB), which is in his opinion a basis for a bullish setup. Worth believes the stock is going to break out on the upside and reach its highs at $181.

Related Link: Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences

Mike Khouw thinks the best way to make a bullish bet is by selling the October 165 put for $6.70. The trade starts to lose money below $158.30, or 4.45 percent lower from the current stock price. If Amgen stays above $165 at the October expiration, Khouw is going to collect 4 percent in three months.

Full ratings data available on Benzinga Pro.

Did you like this article? Could it have been improved? Please email with the story link to let us know!

Posted-In: Biotech Long Ideas Health Care Technicals Options Markets Media Trading Ideas Best of Benzinga


Related Articles (AMGN + IBB)

View Comments and Join the Discussion!

When You've Hit The Bottom And Start Scraping: Too Much Month At The End Of Your Paycheck

Barclays To GM: Dividend Play Or Growth Story, Pick One And Stick With It